Related Experiment Videos
Continuous venous access in children for long-term chemotherapy by means of an implantable system
Insights
Port-a-Cath (PAC) systems offer a safe and effective method for continuous venous access in pediatric chemotherapy patients. This implantable system reduces infection risk and improves patient comfort compared to other venous access methods.
Area of Science:
- Pediatric Oncology
- Medical Devices
- Surgical Procedures
Background:
- Long-term chemotherapy in children requires reliable venous access.
- Traditional percutaneous systems pose risks of infection and discomfort.
- Totally implantable devices offer an alternative for venous access.
Purpose of the Study:
- To evaluate the efficacy and safety of Port-a-Cath (PAC) systems for pediatric chemotherapy.
- To assess the complication rate associated with PAC implantation.
- To compare PACs with percutaneous systems regarding patient comfort and infection risk.
Main Methods:
- Implantation of 42 Port-a-Cath (PAC) systems in pediatric patients (aged 1-16 years).
- Study period: June 1983 to December 1984.
- Continuous venous access was established for long-term chemotherapy.
Main Results:
- The Port-a-Cath (PAC) system is a totally implantable closed device.
- Absence of permanent skin penetration significantly decreases infection risk.
- PACs provide greater freedom and less discomfort for pediatric patients.
Conclusions:
- Port-a-Cath (PAC) systems are a viable option for venous access in pediatric chemotherapy.
- The complication rate appears acceptable compared to alternative methods.
- PACs enhance quality of life for children undergoing long-term treatment.
Abstract:
Between June 1983 and December 1984, 42 Port-a-Cath (PAC) systems have been implanted to establish continuous venous access in 42 children (aged 1 to 16 years) undergoing long-term chemotherapy. The PAC is a totally implantable closed system. Absence of permanent skin penetration decreases the risk of infection. The PAC gives more freedom and less discomfort to the child than a percutaneous system. The complication rate seems acceptable in comparison with that of other methods.